Researchers performed a meta-analysis that included eight cohort studies and six case-control and cross-sectional studies in order to evaluate how hepatitis C virus (HCV) infection is associated with coronary artery diseases (CAD). There was no evidence of publication bias. Two independent reviewers extracted the data and calculated the pooled odds ratio and relative risk with 95% confidence interval using the fixed and the random effects models. Outcomes suggested HCV infection as a risk factor for CAD.

The study is aimed at assessing the safety and immunogenicity of HCV prime-boost vaccinations ChAd3-hliNSmut and MVA-hliNSmut, administered intramuscularly in healthy volunteers and DAA treated patients. To read the entire study, click here Share This PageFollow Us … Continue reading → The post The study is aimed at assessing the safety and immunogenicity of HCV […]

The purpose of this study is to evaluate the efficacy and tolerability of DAA-based regimens in the clinical practice in HIV/HCV-coinfected patients. Hypothesis: The efficacy and tolerability of all DAA-based regimens in the clinical practice is different to what is … Continue reading → The post Real-life Security and Efficacy of DAA-based Therapy in 1,000 […]